Sign in

CIK 0001541157 · Non-accelerated filer<br>Smaller reporting company

Akari Therapeutics Plc

Sign in to watch
Ticker
AKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
EIN
981034922
Phone
(929) 274-7510
Business address
401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
Former names
Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
  1. EFFECT Other Notice of Effectiveness
  2. EFFECT Other Notice of Effectiveness
  3. EFFECT Other Notice of Effectiveness
  4. 6-K Event Report of Foreign Issuer
  5. 4 Open-market buy 10% owner bought 16,203 shares at an average $6.66 ($107,947)
  6. 4 Open-market buy 10% owner bought 11,100 shares at an average $6.83 ($75,791)
  7. 20-F Report Annual and Transition Report of Foreign Private Issuers
  8. 3 Insider Initial Statement of Ownership
  9. POS AM Other Post-effective Amendment for Registration Statement
  10. POS AM Other Post-effective Amendment for Registration Statement
  11. POS AM Other Post-effective Amendment for Registration Statement
  12. 424B3 Offering Prospectus
  13. 424B3 Offering Prospectus
  14. 6-K Event Report of Foreign Issuer
  15. 424B3 Offering Prospectus
  16. 424B3 Offering Prospectus
  17. 6-K Event Report of Foreign Issuer
  18. 6-K Event Report of Foreign Issuer
  19. 424B4 Offering Prospectus
  20. CERTNAS Other Certification by the Nasdaq Stock Market

Page 34 of 38 · 746 filings